Inflammatory markers in a randomised soya intervention among men

British Journal of Nutrition

Volumn 101, Issue 12, 2009, Pages 1740-1744

  Maskarinec, Gertraud ^a   Oum, Robert ^a   Chaptman, Ann K ^b   Ognjanovic, Simona ^b  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adiposity; Dietary interventions; Inflammation; Men; Soya

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; ISOFLAVONE DERIVATIVE;

ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DIETARY INTAKE; ETHNICITY; HUMAN; INFLAMMATION; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; AGED; BLOOD; COMPARATIVE STUDY; DIET; MIDDLE AGED; MULTIVARIATE ANALYSIS;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHEMOKINE CCL4; DIET; HUMANS; INTERLEUKIN-6; ISOFLAVONES; LEPTIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEANS;

EID: 69849106570     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508147389     Document Type: Article

References (31)

1. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3, 364-373.
2. Ford D (2002) Mechanistic explanations for the chemopreventive action of soyabean isoflavones: reducing the possibilities. Br J Nutr 88, 439-441.
3. Verdrengh M, Jonsson IM, Holmdahl R, et al. (2003) Genistein as an anti-inflammatory agent. Inflamm Res 52, 341-346.
4. Register TC, Cann JA, Kaplan JR, et al. (2005) Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab 90, 1734-1740.
5. Ryan-Borchers TA, Park JS, Chew BP, et al. (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83, 1118-1125.
6. Nasca MM, Zhou JR & Welty FK (2008) Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 102, 84-86.
7. Coussens LM & Werb Z (2002) Inflammation and cancer. Nature 420, 860-867.
8. James MJ, Gibson RA & Cleland LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71, 343S-348S.
9. Maskarinec G, Morimoto Y, Hebshi S, et al. (2006) Serum prostate- specific antigen but not testosterone levels decrease in a randomized soy intervention among men. Eur J Clin Nutr 60, 1423-1429.
10. Garofalo C & Surmacz E (2006) Leptin and cancer. J Cell Physiol 207, 12-22.
11. Tilg H & Wolf AM (2005) Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 9, 245-251.
12. Ishihara K & Hirano T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13, 357-368.
13. Albert MA, Glynn RJ, Buring J, et al. (2004) C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93, 1238-1242.
14. Gerhardt CC, Romero IA, Cancello R, et al. (2001) Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 175, 81-92.
15. Sartipy P & Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100, 7265-7270.
16. Maskarinec G, Aylward AG, Erber E, et al. (2008) Soy intake is related to a lower body mass index in adult women. Eur J Nutr 47, 138-144.
17. Gonzalez C, Cava F, Ayllon A, et al. (2001) Biological variation of interleukin-1b, interleukin-8 and tumor necrosis factor-a in serum of healthy individuals. Clin Chem Lab Med 39, 836-841.
18. Lamartiniere CA, Cotroneo MS & Fritz WA (2002) Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132, 552S-558S.
19. Phipps WR, Wangen KE, Duncan AM, et al. (2001) Lack of effect of isoflavonic phytoestrogen intake on leptin concentrations in premenopausal and postmenopausal women. Fertil Steril 75, 1059-1064.
20. Hall WL, Vafeiadou K, Hallund J, et al. (2005) Soy-isoflavoneenriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82, 1260-1268.
21. Yildiz MF, Kumru S, Godekmerdan A, et al. (2005) Effects of raloxifene, hormone therapy, and soy isoflavone on serum highsensitive C-reactive protein in postmenopausal women. Int J Gynaecol Obstet 90, 128-133.
22. Jenkins DJ, Kendall CW, Jackson CJ, et al. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76, 365-372.
23. Campbell CG, Brown BD, Dufner D, et al. (2006) Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 41, 257-265.
24. Considine RV, Sinha MK, Heiman ML, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292-295.
25. Malavazos AE, Cereda E, Morricone L, et al. (2005) Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur J Endocrinol 153, 871-877.
26. Yamashita T, Sasahara T, Pomeroy SE, et al. (1998) Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 47, 1308-1314.
27. Troseid M, Lappegard KT, Claudi T, et al. (2004) Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 25, 349-355.
28. Ghanim H, Aljada A, Hofmeyer D, et al. (2004) Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110, 1564-1571.
29. Kim CS, Park HS, Kawada T, et al. (2006) Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30, 1347-1355.
30. Reape TJ & Groot PH (1999) Chemokines and atherosclerosis. Atherosclerosis 147, 213-225.
31. Xu H, Barnes GT, Yang Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830.